Developer docs
API playgroundTry for free, no card

Search company profiles

CTIS

Full company profile

uuid0009mma

Namestring
CTIS
Legal namestring
CTIS, Inc.
Websiteurl
ctisinc.com
Company typeenum
Private
Founded yearint
1993
Descriptiontext

CTIS, Inc. is a privately held, Women-Owned Small Business headquartered in Rockville, Maryland, with over 30 years of experience in health IT and clinical research informatics. The company provides end-to-end Health IT services including Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure and Security, and DevSecOps, primarily to federal healthcare and research agencies (NIH, FDA, VA, CMS, FDIC) and academic medical institutions (Georgetown University, Johns Hopkins, Moffitt Cancer Center). CTIS holds ISO 9001, ISO 27001, ISO 20000-1, and CMMI Level 3 certifications, AWS Partner status, and access to multiple federal contract vehicles (GSA MAS, CIO-SP3 SB, NCI CBBIIT PITS BPA, SPARC-SB, FDIC ITAS NG BOA) that anchor its government services revenue.

In April 2026, CTIS launched Trial SafetyXchange, a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting. The product is targeted at small and mid-size pharmaceutical companies, biotech firms, and contract research organizations facing the FDA's April 1, 2026 compliance deadline and positioned as a low-cost, immediately deployable alternative to enterprise pharmacovigilance platforms. CTIS combines subscription SaaS revenue from Trial SafetyXchange with managed and professional services revenue from its federal health IT practice, distributed through a sales-led enterprise motion with quote-based engagement and no public pricing.

Short descriptiontext

CTIS is a Rockville, Maryland-based Women-Owned Small Business providing health IT services to federal healthcare agencies and academic medical centers, and in April 2026 launched Trial SafetyXchange, a SaaS platform that automates FDA E2B(R3) adverse event reporting compliance for pharma, biotech, and CRO customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersRockville, United States
HQ citystring
Rockville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
health IT services, clinical trial compliance, FDA regulatory solutions, health informatics, IT modernization
Industry3 codes
1Safety/Pharmacovigilance (PV) & Clinical Safety Systems
CodeHLACAOAHPrimaryYes
2Clinical Trial Management Systems (CTMS)
CodeHLACAOADPrimaryNo
3Safety Database Operations & Hosting (Argus/ARISg/Oracle)
CodeHLAGALABPrimaryNo
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Health IT Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1SaaS Subscription (Trial SafetyXchange)
TypeSubscription Recurring
Description

Cloud-based SaaS subscription model for the Trial SafetyXchange platform. Offers immediate deployment as an affordable alternative to traditional enterprise compliance platforms for FDA E2B(R3) compliance.

businesswire.com
2Health IT Services
TypeManaged Services
Description

End-to-end solutions including Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps delivered as professional services and managed services.

ctisinc.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Trial SafetyXchange
Description

Cloud-based SaaS solution that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance.

morningstar.com
Core offering1 text field

CTIS is a Health IT and clinical research informatics company that delivers end-to-end solutions spanning Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps. Its flagship product, Trial SafetyXchange, is a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance ahead of the April 1, 2026 deadline.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Addresses FDA April 1, 2026 compliance deadline for adverse event reporting
Product overview1 text field

CTIS offers a portfolio of Health IT and clinical research informatics solutions. The primary product is Trial SafetyXchange, a cloud-based SaaS platform designed for FDA compliance in clinical trials. The company also provides end-to-end solutions including Data Services, Health Information Solutions, IT Modernization, and AI/ML Enablement capabilities.

Product and service2 records
1Trial SafetyXchange
CategoryClinical Trial Compliance Software
Description

A cloud-based SaaS solution that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard, helping pharmaceutical companies, biotech firms, and CROs meet the April 1, 2026 compliance deadline for adverse event reporting in clinical trials.

2Health IT End-to-End Solutions
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeTechnology or Integration
Description

CTIS holds AWS Partner status, indicating cloud infrastructure and technology integration partnership for delivering SaaS solutions.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

CTIS holds multiple government contract vehicles including GSA Multiple Award Schedule, CIO-SP3 SB, NCI CBBIIT PITS BPA, SPARC-SB, and FDIC ITAS NG BOA, enabling direct procurement by federal agencies including NIH, FDA, VA, and CMS.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Leidos is a large federal health IT contractor serving NIH, FDA, VA, and CMS — directly overlapping CTIS's federal healthcare agency customer base and contract vehicle footprint.

TypeDirect peer
Description

TrackWise provides quality and safety management for pharma, including adverse event and case management workflows overlapping with CTIS's Trial SafetyXchange use case.

TypeDirect peer
Description

Veeva's Vault Safety is a leading cloud-based pharmacovigilance platform for adverse event reporting and ICSR management, directly competing with CTIS's Trial SafetyXchange for the same pharma/biotech/CRO buyer.

TypeOthers
Description

Parexel is a global CRO that relies on pharmacovigilance and safety reporting technology for its sponsor clients, making it a potential channel partner and indirect buyer profile for Trial SafetyXchange.

TypeBroad incumbent
Description

IQVIA is a global CRO and health IT provider with safety/pharmacovigilance services and technology; it operates across the full clinical trial lifecycle that CTIS targets via its narrower SMB-focused SaaS offering.

TypeDirect peer
Description

ArisGlobal's LifeSphere Safety platform provides pharmacovigilance, case management, and E2B submission software, competing head-on with Trial SafetyXchange for pharma safety teams.

TypeEmerging player
Description

Saama provides AI-enabled clinical trial and pharmacovigilance analytics, competing with CTIS in clinical research informatics SaaS for pharma and biotech with overlapping buyer personas.

TypeBroad incumbent
Description

Booz Allen is a major federal health IT and digital modernization contractor, comparable to CTIS's federal health IT services arm across NIH, FDA, VA, and CMS engagements.

TypeDirect peer
Description

Medidata's clinical trial technology suite includes safety reporting and E2B submission capabilities serving pharma and CROs, an adjacent but comparable offering to CTIS's Trial SafetyXchange.

TypeDirect peer
Description

Oracle's Argus Safety is the dominant enterprise safety database for ICSR/E2B submissions and adverse event reporting, the primary incumbent CTIS positions Trial SafetyXchange against for SMB and mid-market pharma.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CTIS

Health IT Servicesctisinc.com

CTIS is a Rockville, Maryland-based Women-Owned Small Business providing health IT services to federal healthcare agencies and academic medical centers, and in April 2026 launched Trial SafetyXchange, a SaaS platform that automates FDA E2B(R3) adverse event reporting compliance for pharma, biotech, and CRO customers.

What CTIS does

CTIS, Inc. is a privately held, Women-Owned Small Business headquartered in Rockville, Maryland, with over 30 years of experience in health IT and clinical research informatics. The company provides end-to-end Health IT services including Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure and Security, and DevSecOps, primarily to federal healthcare and research agencies (NIH, FDA, VA, CMS, FDIC) and academic medical institutions (Georgetown University, Johns Hopkins, Moffitt Cancer Center). CTIS holds ISO 9001, ISO 27001, ISO 20000-1, and CMMI Level 3 certifications, AWS Partner status, and access to multiple federal contract vehicles (GSA MAS, CIO-SP3 SB, NCI CBBIIT PITS BPA, SPARC-SB, FDIC ITAS NG BOA) that anchor its government services revenue.

In April 2026, CTIS launched Trial SafetyXchange, a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting. The product is targeted at small and mid-size pharmaceutical companies, biotech firms, and contract research organizations facing the FDA's April 1, 2026 compliance deadline and positioned as a low-cost, immediately deployable alternative to enterprise pharmacovigilance platforms. CTIS combines subscription SaaS revenue from Trial SafetyXchange with managed and professional services revenue from its federal health IT practice, distributed through a sales-led enterprise motion with quote-based engagement and no public pricing.

CTIS firmographics

Firmographics
Name
CTIS
Legal name
CTIS, Inc.
Website
https://ctisinc.com
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
101–250 employees
Short description
CTIS is a Rockville, Maryland-based Women-Owned Small Business providing health IT services to federal healthcare agencies and academic medical centers, and in April 2026 launched Trial SafetyXchange, a SaaS platform that automates FDA E2B(R3) adverse event reporting compliance for pharma, biotech, and CRO customers.
Ownership category
akta.pro rank

CTIS industry classification

Industry
Product category
Health IT Services
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro primary industry
Safety/Pharmacovigilance (PV) & Clinical Safety Systems (HLACAOAH)
akta.pro secondary industries
Clinical Trial Management Systems (CTMS) (HLACAOAD), Safety Database Operations & Hosting (Argus/ARISg/Oracle) (HLAGALAB)

Keywords

  • Health IT services
  • Clinical trial compliance
  • FDA regulatory solutions
  • Health informatics
  • IT modernization

Where CTIS is headquartered

Location

Headquarters

HQ city
Rockville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

CTIS business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. SaaS Subscription (Trial SafetyXchange): Cloud-based SaaS subscription model for the Trial SafetyXchange platform. Offers immediate deployment as an affordable alternative to traditional enterprise compliance platforms for FDA E2B(R3) compliance.
  2. Health IT Services: End-to-end solutions including Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps delivered as professional services and managed services.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

CTIS product offering

Product offering

Core offering

CTIS is a Health IT and clinical research informatics company that delivers end-to-end solutions spanning Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps. Its flagship product, Trial SafetyXchange, is a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance ahead of the April 1, 2026 deadline.

Product overview

CTIS offers a portfolio of Health IT and clinical research informatics solutions. The primary product is Trial SafetyXchange, a cloud-based SaaS platform designed for FDA compliance in clinical trials. The company also provides end-to-end solutions including Data Services, Health Information Solutions, IT Modernization, and AI/ML Enablement capabilities.

Differentiator

Problem solved

Functional benefit

Brands

  • Trial SafetyXchange: Cloud-based SaaS solution that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance.

Products and services

  • Trial SafetyXchange A cloud-based SaaS solution that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard, helping pharmaceutical companies, biotech firms, and CROs meet the April 1, 2026 compliance deadline for adverse event reporting in clinical trials.
  • Health IT End-to-End Solutions

Quantifiable outcome

  • Addresses FDA April 1, 2026 compliance deadline for adverse event reporting

Companies that use CTIS

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

CTIS technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

CTIS partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and flagship.

  • AWS (Amazon Web Services)coreTechnology or IntegrationCTIS holds AWS Partner status, indicating cloud infrastructure and technology integration partnership for delivering SaaS solutions.
  • U.S. Federal GovernmentflagshipStrategic or Co-development PartnerCTIS holds multiple government contract vehicles including GSA Multiple Award Schedule, CIO-SP3 SB, NCI CBBIIT PITS BPA, SPARC-SB, and FDIC ITAS NG BOA, enabling direct procurement by federal agencies including NIH, FDA, VA, and CMS.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

CTIS competitors and assessment

Company assessment

Broad incumbents

  • Leidos: Leidos is a large federal health IT contractor serving NIH, FDA, VA, and CMS — directly overlapping CTIS's federal healthcare agency customer base and contract vehicle footprint.
  • IQVIA: IQVIA is a global CRO and health IT provider with safety/pharmacovigilance services and technology; it operates across the full clinical trial lifecycle that CTIS targets via its narrower SMB-focused SaaS offering.
  • Booz Allen Hamilton: Booz Allen is a major federal health IT and digital modernization contractor, comparable to CTIS's federal health IT services arm across NIH, FDA, VA, and CMS engagements.

Direct peers

  • Sparta Systems (TrackWise): TrackWise provides quality and safety management for pharma, including adverse event and case management workflows overlapping with CTIS's Trial SafetyXchange use case.
  • Veeva Systems: Veeva's Vault Safety is a leading cloud-based pharmacovigilance platform for adverse event reporting and ICSR management, directly competing with CTIS's Trial SafetyXchange for the same pharma/biotech/CRO buyer.
  • ArisGlobal: ArisGlobal's LifeSphere Safety platform provides pharmacovigilance, case management, and E2B submission software, competing head-on with Trial SafetyXchange for pharma safety teams.
  • Dassault Systèmes (Medidata): Medidata's clinical trial technology suite includes safety reporting and E2B submission capabilities serving pharma and CROs, an adjacent but comparable offering to CTIS's Trial SafetyXchange.
  • Oracle Health Sciences (Argus Safety): Oracle's Argus Safety is the dominant enterprise safety database for ICSR/E2B submissions and adverse event reporting, the primary incumbent CTIS positions Trial SafetyXchange against for SMB and mid-market pharma.

Others

  • Parexel International: Parexel is a global CRO that relies on pharmacovigilance and safety reporting technology for its sponsor clients, making it a potential channel partner and indirect buyer profile for Trial SafetyXchange.

Emerging players

  • Saama Technologies: Saama provides AI-enabled clinical trial and pharmacovigilance analytics, competing with CTIS in clinical research informatics SaaS for pharma and biotech with overlapping buyer personas.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key highlights7 records

Customer concentration

CTIS social profiles

Digital presence

CTIS compliance and trust

Trust signal

Compliance4 records

CTIS financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CTIS leadership team

Management profile

Number of profiles

CTIS funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CTIS M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CTIS

What does CTIS do?

CTIS is a Health IT and clinical research informatics company that delivers end-to-end solutions spanning Data Services, Health Information Solutions, IT Modernization, AI/ML Enablement, IT Infrastructure & Security, and DevSecOps. Its flagship product, Trial SafetyXchange, is a cloud-based SaaS platform that automates the conversion of Individual Case Safety Report (ICSR) files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard for adverse event reporting compliance ahead of the April 1, 2026 deadline.

Is CTIS a public or private company?

CTIS is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was CTIS founded?

CTIS was founded in 1993. It employs 101 to 250 people.

Where is CTIS based?

CTIS is headquartered in Rockville, United States, in the North America region.

How does CTIS make money?

Two revenue lines are on record. SaaS Subscription (Trial SafetyXchange) is the primary driver. The others are health IT Services.

Who are CTIS's main competitors?

Broad incumbents on record are Leidos, IQVIA and Booz Allen Hamilton. Direct peers are Sparta Systems (TrackWise), Veeva Systems, ArisGlobal, Dassault Systèmes (Medidata) and Oracle Health Sciences (Argus Safety). Parexel International is listed as an others. Saama Technologies is listed as an emerging player.

Does CTIS have an API?

No public API is recorded for CTIS.

What industry is CTIS in?

CTIS's product category is Health IT Services. Its primary akta.pro industry code is HLACAOAH, Safety/Pharmacovigilance (PV) & Clinical Safety Systems, with a secondary code of HLACAOAD, Clinical Trial Management Systems (CTMS). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
National TodayCTIS Launches Trial SafetyXchange for FDA ComplianceCTIS, Inc. has launched Trial SafetyXchange, a cloud-based platform designed to help pharmaceutical companies comply with the FDA E2B(R3) adverse event reporting standard, which is a new global format for clinical trial safety reporting. The platform automates conversion of adverse event data, integrates with existing clinical trial management systems, and provides tools for data mapping, validation, and submission. Pharmaceutical companies must achieve compliance before the end-of-year 2026 deadline or face potential penalties and delays.MorningstarCTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance DeadlineCTIS, Inc. announced the commercial launch of Trial SafetyXchange, a cloud-based SaaS solution designed to help pharmaceutical companies, biotech firms, and contract research organizations convert Individual Case Safety Report files from the FDA-mandated E2B (R2) format to the E2B (R3) standard. The solution addresses the FDA's April 1, 2026 compliance deadline by offering an affordable, immediately deployable alternative to expensive enterprise platforms. CTIS, Inc. is a Women-Owned Small Business headquartered in Rockville, Maryland, with over 30 years of experience in health IT and clinical research informatics.PharmiWeb.comCTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance DeadlineCTIS, Inc. announced the commercial launch of Trial SafetyXchange, a cloud-based SaaS solution that automates the conversion of Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard. The solution targets small and mid-size pharmaceutical companies, biotech firms, and contract research organizations facing the FDA's April 1, 2026 compliance deadline, offering a cost-effective alternative to traditional enterprise systems to avoid potential regulatory penalties.Business Wire BlogCTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance DeadlineCTIS, Inc. announced the commercial launch of Trial SafetyXchange, a cloud-based SaaS solution designed to help small and mid-size pharmaceutical companies, biotech firms, and contract research organizations convert Individual Case Safety Report files from the legacy E2B(R2) format to the FDA-mandated E2B(R3) standard. The solution addresses the upcoming April 1, 2026 compliance deadline, offering organizations a lower-cost alternative to traditional enterprise compliance platforms. CTIS, a Women-Owned Small Business headquartered in Maryland with over 30 years of Health IT experience, positions the launch as removing barriers to compliance for companies that lack large enterprise budgets.